Concepedia

Ling-Yan Cai

LC

Statistics

Publications

5

Citations

299

H-Index

5

Active since

2019

Affiliations

Shanghai East Hospital(Current)

Second Military Medical University

Shanghai Changzheng Hospital

Shanghai Institute of Materia Medica

Qingdao National Laboratory for Marine Science and Technology

Ling-Yan Cai is an author at Shanghai East Hospital specializing in hepatocellular carcinoma pathogenesis, cancer epigenetics, and epigenetic regulation in cancer.

ORCID

Publications per year

2019–2025

5

Publications

5

Targeting p300/CBP Attenuates Hepatocellular Carcinoma Progression through Epigenetic Regulation of Metabolism

Ling-Yan Cai, Shijie Chen, Sen-Hao Xiao et al. · Cancer Research · 2020 · 173 citations · Full text

, , +17

Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4α

Bai-Nan Zheng, Chen‐Hong Ding, Shijie Chen et al. · Theranostics · 2019 · 46 citations · Full text

, , +17

PRMT3 drives PD-L1-mediated immune escape through activating PDHK1-regulated glycolysis in hepatocellular carcinoma

Chen‐Hong Ding, Fang‐Zhi Yan, Hui Qian et al. · Cell Death and Disease · 2025 · 33 citations · Full text

, , +17

Gut Microbial Profile in Asymptomatic Gallstones

Sen-Tao Song, Ling-Yan Cai, Xin Zeng et al. · Frontiers in Microbiology · 2022 · 25 citations · Full text

, , +17

The Role of Bone Morphogenetic Protein 9 in Nonalcoholic Fatty Liver Disease in Mice

Qin-Juan Sun, Ling-Yan Cai, Jie Jian et al. · Frontiers in Pharmacology · 2021 · 22 citations · Full text

, , +10

1–5 of 5